Items where authors include "Nikiphorou, E"
Article
Shinjo, SK, Kim, M, Hoff, LS et al. (32 more authors) (2023) Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study. International Journal of Rheumatic Diseases, 26 (4). pp. 727-739. ISSN 1756-1841
Sen, P, Naveen, R, Houshmand, N et al. (53 more authors) (2023) Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys. Rheumatology. kead057. ISSN 1462-0324
Hoff, LS, Ravichandran, N, Shinjo, SK et al. (39 more authors) (2023) COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey. Rheumatology International, 43 (1). pp. 47-58. ISSN 0172-8172
Sen, P, Ravichandran, N, Nune, A et al. (27 more authors) (2023) COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study. Rheumatology, 62 (1). pp. 65-76. ISSN 1462-0324
Fazal, ZZ, Sen, P, Joshi, M et al. (33 more authors) (2022) COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology International, 42 (12). pp. 2151-2158. ISSN 0172-8172
R, N, Nikiphorou, E, Joshi, M et al. (23 more authors) (2022) Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study. Rheumatology. keac661. ISSN 1462-0324
Naveen, R, Parodis, I, Joshi, M et al. (21 more authors) (2022) COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis. Rheumatology. keac624. ISSN 1462-0324
Dey, M, Naveen, R, Nikiphorou, E et al. (92 more authors) (2022) Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology. keac603. ISSN 1462-0324
Gil‐Vila, A, Naveen, R, Selva‐O'Callaghan, A et al. (32 more authors) (2022) COVID‐19 Vaccination In Autoimmune Diseases (COVAD) Study: Vaccine Safety In Idiopathic Inflammatory Myopathies. Muscle & Nerve, 66 (4). pp. 426-437. ISSN 0148-639X
Ovseiko, PV, Gossec, L, Andreoli, L et al. (21 more authors) (2022) Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force. RMD Open, 8 (2). e002518. ISSN 2056-5933
Yoshida, A, Kim, M, Kuwana, M et al. (30 more authors) (2022) Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey. Rheumatology. keac441. ISSN 1462-0324
Tan, AL orcid.org/0000-0002-9158-7243, Sen, P, Gupta, L et al. (23 more authors) (2022) Vaccine Hesitancy in Patients with Autoimmune Diseases Data from the Coronavirus Disease-2019 Vaccination in Autoimmune Diseases Study. Indian Journal of Rheumatology, 17 (2). pp. 188-191. ISSN 0973-3698
de la Torre-Aboki, J, Uson, J, Pitsillidou, I et al. (15 more authors) (2022) Intra-articular therapies: patient preferences and professional practices in European countries. Rheumatology International, 42 (5). pp. 869-878. ISSN 0172-8172
Sen, P, Gupta, L, Lilleker, JB et al. (82 more authors) (2022) COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatology International, 42 (1). pp. 23-29. ISSN 0172-8172
Rodriguez-García, SC, Castellanos-Moreira, R, Uson, J et al. (15 more authors) (2021) Efficacy and safety of intra-articular therapies in rheumatic and musculoskeletal diseases: an overview of systematic reviews. RMD Open, 7 (2). e001658. ISSN 2056-5933
Uson, J, Rodriguez-García, SC, Castellanos-Moreira, R et al. (15 more authors) (2021) EULAR recommendations for intra-articular therapies. Annals of the Rheumatic Diseases. ISSN 0003-4967
Kim, HU, Alten, R, Cummings, F et al. (14 more authors) (2021) Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters. mAbs, 13 (1). 1868078. ISSN 1942-0862
Twigg, S, Nikiphorou, E, Nam, JL et al. (6 more authors) (2018) Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis. Frontiers in Medicine, 5. 35. ISSN 2296-858X
Nikiphorou, E, Buch, MH orcid.org/0000-0002-8962-5642 and Hyrich, KL (2017) Biologics registers in RA: methodological aspects, current role and future applications. Nature Reviews Rheumatology, 13 (8). pp. 503-510. ISSN 1759-4790
Nikiphorou, E, Mackie, SL, Kirwan, J et al. (4 more authors) (2017) Achieving consensus on minimum data items (including core outcome domains) for a longitudinal observational cohort study in rheumatoid arthritis. Rheumatology, 56 (4). pp. 550-555. ISSN 1462-0324
Conference or Workshop Item
Sen, P, R, N, Nune, A et al. (26 more authors) (2022) COVID-19 VACCINATION-RELATED ADVERSE EVENTS AMONG AUTOIMMUNE DISEASE PATIENTS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Grignaschi, S, Cavagna, L, Kim, M et al. (28 more authors) (2022) HIGH FATIGUE SCORES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A MULTIGROUP COMPARATIVE STUDY FROM THE COVAD E-SURVEY. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Yoshida, A, Kim, M, Kuwana, M et al. (29 more authors) (2022) IMPAIRED PROMIS PHYSICAL FUNCTION IN IDIOPATHIC INFLAMMATORY MYOPATHY PATIENTS: RESULTS FROM THE MULTICENTER COVAD PATIENT REPORTED E-SURVEY. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Gupta, L, Hoff, LS, R, N et al. (28 more authors) (2022) POS0201 COVID-19 SEVERITY AND VACCINE BREAKTHROUGH INFECTIONS IN IDIOPATHIC INFLAMMATORY MYOPATHIES, OTHER SYSTEMIC AUTOIMMUNE AND INFLAMMATORY DISEASES, AND HEALTHY INDIVIDUALS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2021, Copenhagen, Denmark.
Aoude, M, Gupta, L, Hmamouchi, I et al. (30 more authors) (2022) TREATMENT PATTERNS OF IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM AN INTERNATIONAL COHORT OF OVER 1,400 PATIENTS. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Ovseiko, PV, Gossec, L, Andreoli, L et al. (21 more authors) (2020) THU0580: EULAR Task Force on Gender Equity in Academic Rheumatology: Preliminary Survey Findings. In: European League Against Rheumatism (EULAR) 2020, 03-06 Jun 2020, Online.
Proceedings Paper
R, N, Joshi, M, Sen, P et al. (39 more authors) (2022) Vaccine Hesitancy Among Patients with Idiopathic Inflammatory Myopathies and Rheumatic Diseases in 2021-2022: A Comparative Analysis of COVID-19 Vaccination in Autoimmune Diseases Surveys. In: Arthritis and Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 3717-3720.
Studenic, P, Alunno, A, Stones, SR orcid.org/0000-0002-5943-1310 et al. (2 more authors) (2018) Social Media Use for Health-Related Purposes By People with Rheumatic and Musculoskeletal Diseases - Results of a Global Survey. In: Arthritis & Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .